DK1819230T3 - Erytrocytafledte mikropartikler som hæmostatiske midler til kontrol af hæmoragi og til behandling af blødningsforstyrrelser - Google Patents

Erytrocytafledte mikropartikler som hæmostatiske midler til kontrol af hæmoragi og til behandling af blødningsforstyrrelser

Info

Publication number
DK1819230T3
DK1819230T3 DK05849361.0T DK05849361T DK1819230T3 DK 1819230 T3 DK1819230 T3 DK 1819230T3 DK 05849361 T DK05849361 T DK 05849361T DK 1819230 T3 DK1819230 T3 DK 1819230T3
Authority
DK
Denmark
Prior art keywords
microparticles
hemoragy
erytrocyta
flated
treatment
Prior art date
Application number
DK05849361.0T
Other languages
English (en)
Inventor
Wenche Jy
Lawrence L Horstmann
Yeon S Ahn
Joaquin J Jimenez
Eugene Ahn
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Application granted granted Critical
Publication of DK1819230T3 publication Critical patent/DK1819230T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05849361.0T 2004-12-07 2005-12-07 Erytrocytafledte mikropartikler som hæmostatiske midler til kontrol af hæmoragi og til behandling af blødningsforstyrrelser DK1819230T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63341704P 2004-12-07 2004-12-07
PCT/US2005/044064 WO2006062945A2 (en) 2004-12-07 2005-12-07 Cell-derived microparticles as hemostatic agents for control of hemorrhage and treatment of bleeding disorders

Publications (1)

Publication Number Publication Date
DK1819230T3 true DK1819230T3 (da) 2012-08-20

Family

ID=36578476

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05849361.0T DK1819230T3 (da) 2004-12-07 2005-12-07 Erytrocytafledte mikropartikler som hæmostatiske midler til kontrol af hæmoragi og til behandling af blødningsforstyrrelser

Country Status (9)

Country Link
US (1) US8105632B2 (da)
EP (1) EP1819230B1 (da)
JP (1) JP5204490B2 (da)
AT (1) ATE555799T1 (da)
DK (1) DK1819230T3 (da)
ES (1) ES2390317T3 (da)
PL (1) PL1819230T3 (da)
PT (1) PT1819230E (da)
WO (1) WO2006062945A2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9155764B1 (en) * 2004-12-07 2015-10-13 University Of Miami Expanded utility of red-cell derived microparticles (RMP) for treatment of bleeding
JP2009504803A (ja) 2005-08-22 2009-02-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｔｌｒアゴニスト
CN101790380B (zh) 2007-02-07 2013-07-10 加利福尼亚大学董事会 合成tlr激动剂的缀合物及其应用
FR2917172B1 (fr) * 2007-06-07 2014-01-03 Inst Nat Sante Rech Med Methode de mesure de l'activite plasmine des microparticules presentes dans un echantillon de fluide biologique et utilisation
US20090062233A1 (en) 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis
EP2449384B1 (en) * 2009-07-01 2016-04-20 INSERM - Institut National de la Santé et de la Recherche Médicale Methods for predicting cardiovascular mortality risk
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
PL2668262T3 (pl) * 2011-01-28 2018-04-30 University Of Miami Rozszerzone wykorzystanie mikrocząstek pochodzących z czerwonych krwinek (RMP) do leczenia krwawienia
JP2012168012A (ja) * 2011-02-14 2012-09-06 Nippon Koden Corp 血管内皮障害を検査するための新規な検査方法および検査用キット
WO2012135032A2 (en) * 2011-03-25 2012-10-04 The Brigham And Women's Hospital, Inc. Anti-inflammatory particles
WO2015069897A1 (en) 2013-11-07 2015-05-14 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Red blood cell membrane-derived microparticles and their use for the treatment of lung disease
CN105793411B (zh) 2013-11-16 2018-04-17 泰尔茂比司特公司 生物反应器中的细胞扩增
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
WO2015179301A1 (en) * 2014-05-19 2015-11-26 Eleftherios Papoutsakis Megakaryocytic particles and microparticles for cell therapy & fate modification of stem and progenitor cells
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
US10722608B2 (en) 2015-03-04 2020-07-28 University Of Rochester Systemic and topical application of platelet microparticles to treat bleeding in trauma patients
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US10543286B2 (en) 2015-10-07 2020-01-28 The Research Foundation For The State University Of New York Methods for increasing platelet count by inhibiting biliverdin IXβ reductase
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. CELL EXPANSION
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP6896516B2 (ja) * 2016-07-25 2021-06-30 シスメックス株式会社 血液分析装置および血液分析方法
RU2768743C2 (ru) * 2016-11-30 2022-03-24 Юниверсити Оф Майами Композиция на основе rmp и способы ее применения
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656841A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529521A (ja) * 1998-11-12 2002-09-10 ノヴォリティックス インコーポレイテッド 血管閉塞を生成する組成物および方法

Also Published As

Publication number Publication date
US8105632B2 (en) 2012-01-31
EP1819230A4 (en) 2009-08-12
PT1819230E (pt) 2012-08-07
US20080069807A1 (en) 2008-03-20
JP5204490B2 (ja) 2013-06-05
EP1819230A2 (en) 2007-08-22
JP2008522974A (ja) 2008-07-03
EP1819230B1 (en) 2012-05-02
WO2006062945A3 (en) 2006-12-07
ES2390317T3 (es) 2012-11-08
ATE555799T1 (de) 2012-05-15
WO2006062945A2 (en) 2006-06-15
PL1819230T3 (pl) 2013-02-28

Similar Documents

Publication Publication Date Title
DK1819230T3 (da) Erytrocytafledte mikropartikler som hæmostatiske midler til kontrol af hæmoragi og til behandling af blødningsforstyrrelser
EP4026835A3 (en) Pd-1/pd-l1 inhibitors
EA201890749A1 (ru) ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ
EA201991862A1 (ru) Композиции и способы, предназначенные для лечения гемоглобинопатий
MX2018009773A (es) Heteroarilos inhibidores de peptidilarginina desiminasa 4 (pad4).
EA201890913A1 (ru) Пиразоловые соединения в качестве ингибиторов акк и их применение
EA201692249A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
EA201891268A1 (ru) Соединения, которые можно применять в качестве ингибиторов киназы
SA518390944B1 (ar) أجسام مضادة لمثبط مسار عامل نسيج واستخداماتها
EA201891251A1 (ru) Бициклические ингибиторы pad4
NO20082125L (no) Substituerte benzokondenserte derivater og deres anvendelse som vanilloidreseptorligander
DE602005014628D1 (de) Embolie-teilchen
ATE553093T1 (de) Indazolderivate zur hemmung von trpv1 und verwendungen davon
EA201692266A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
EA201692268A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
UA99936C2 (en) Biaryl substituted azabicyclic alkane derivatives
EA201692265A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
ATE505191T1 (de) Ectoin zur behandlung von vascular leaks
MX2022001061A (es) Agentes de interleuquina-2 y usos de los mismos.
TR201819781T4 (tr) Kanama Bozukluklarının Tedavisi İçin Modifiye Serpinler
EA201692474A1 (ru) Производные 1-(циклопент-2-ен-1-ил)-3-(2-гидрокси-3-(арилсульфонил)фенил)мочевины в качестве ингибиторов cxcr2
MX2018006700A (es) Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4).
SA519410093B1 (ar) مركبات بيريميدو بيريميدينون مفيدة كمثبطات دبليو إى إى-1 كيناز
CO2020003120A2 (es) Activador akt3 y específico usos de este
EA201501123A8 (ru) Новые (циано-диметил-метил)-изоксазолы и -[1,3,4]тиадиазолы